1. Home
  2. MSBI vs BIOA Comparison

MSBI vs BIOA Comparison

Compare MSBI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

HOLD

Current Price

$23.89

Market Cap

456.2M

Sector

Finance

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$19.52

Market Cap

443.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSBI
BIOA
Founded
1881
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.2M
443.9M
IPO Year
2016
2024

Fundamental Metrics

Financial Performance
Metric
MSBI
BIOA
Price
$23.89
$19.52
Analyst Decision
Hold
Buy
Analyst Count
3
4
Target Price
$22.83
$33.33
AVG Volume (30 Days)
186.4K
1.0M
Earning Date
01-22-2026
03-19-2026
Dividend Yield
5.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$210,718,000.00
$5,917,000.00
Revenue This Year
$28.14
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.24
$2.88
52 Week High
$24.57
$24.00

Technical Indicators

Market Signals
Indicator
MSBI
BIOA
Relative Strength Index (RSI) 71.15 58.94
Support Level $22.43 $18.70
Resistance Level $23.22 $20.66
Average True Range (ATR) 0.72 1.43
MACD -0.02 -0.26
Stochastic Oscillator 81.79 22.76

Price Performance

Historical Comparison
MSBI
BIOA

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: